PTH2 receptor selective compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 12, 2009
Grant Date -
N/A
app pub date -
May 3, 1999
filing date -
May 5, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This invention relates to a series of PTH and PTHrP analogues that selectively bind to PTH2 receptors and as such may be useful in treating abnormal CNS functions; abnormal pancreatic functions; divergence from normal mineral metabolism and homeostasis; male infertility; regulation of abnormal blood pressure; and hypothalmic disease.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully